Antengene (HKG:6996) said its ATG-201 treatment for B cell-related autoimmune diseases has received approval to begin a Phase I clinical trial in Australia.
The study secured Human Research Ethics Committee's approval and completed the Clinical Trial Notification process with Australia's Therapeutic Goods Administration, according to a Tuesday Hong Kong bourse filing.
Qantas Airways' (ASX:QAN) Jetstar unit will operate a new direct route between Melbourne in Victoria and Colombo in Sri Lanka, according to a Tuesday statement.The flights run three times a week, on Tuesdays, Thursdays, and Saturdays.Qantas Airways' shares rose past 1% in recent trading on Tuesday.
Shenzhen Longsys Electronics (SHE:301308) passed its listing hearing with the Hong Kong bourse, paving the way for its proposed secondary offering in the city to proceed, according to a Monday after-hours filing with the Shenzhen Stock Exchange.The semiconductor memory product company plans to use proceeds from the offering to enhance its research and development capabilities, grow its packaging and testing facility in Brazil, boost sales and marketing, fund strategic investments, and for working capital, according to its post-hearing information pack.
Hansen Technologies (ASX:HSN) partnered with InvoiceCloud to integrate its Hansen CIS software products with InvoiceCloud's digital payments platform, according to a Tuesday Australian bourse filing.The firms plan to support bill generation, presentment, payment, and reconciliation for utilities, energy retailers, and local governments across North America.Its shares rose 2% in recent trade on Tuesday.